Results 201 to 210 of about 510,570 (268)
Optimizing Clinical Practice and Efficacy Evaluation of Radiotherapy Combined with Immunotherapy in Recurrent Esophageal Cancer: A Retrospective Cohort Study Focusing on Patient-Reported Pain Relief and Tumor Proliferation Inhibition. [PDF]
J Multidiscip HealthcJi J, Dong L, Huang B, Luo S.
europepmc +1 more source
Patients With Stage III PLCNEC Advocated for Radiotherapy Combined With Chemotherapy While With Stage IV Focus on Individualized Management: Evidence From SEER. [PDF]
Cancer Rep (Hoboken)Zhao Y, Liu G, Li H, Li Y, Lin T, Xie Z.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2011
Solitary plasmocytoma occurring in bone (solitary plasmocytoma of the bone, SBP) or in soft tissue (extramedullary plasmocytoma, EP) can be treated effectively and with little toxicity by local radiotherapy. Ten-year local control rates of up to 90% can be achieved.
Sonja, Krause +2 more
openaire +2 more sources
Solitary plasmocytoma occurring in bone (solitary plasmocytoma of the bone, SBP) or in soft tissue (extramedullary plasmocytoma, EP) can be treated effectively and with little toxicity by local radiotherapy. Ten-year local control rates of up to 90% can be achieved.
Sonja, Krause +2 more
openaire +2 more sources